Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Microchip Technology (MCHPP) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Microchip Technology (MCHPP) over the last 17 years, with Q4 2025 value amounting to $250.7 million.

  • Microchip Technology's Cash & Equivalents fell 5721.84% to $250.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $250.7 million, marking a year-over-year decrease of 5721.84%. This contributed to the annual value of $771.7 million for FY2025, which is 14138.25% up from last year.
  • As of Q4 2025, Microchip Technology's Cash & Equivalents stood at $250.7 million, which was down 5721.84% from $236.8 million recorded in Q3 2025.
  • Over the past 5 years, Microchip Technology's Cash & Equivalents peaked at $771.7 million during Q1 2025, and registered a low of $234.0 million during Q1 2023.
  • Its 5-year average for Cash & Equivalents is $339.4 million, with a median of $287.5 million in 2022.
  • The largest annual percentage gain for Microchip Technology's Cash & Equivalents in the last 5 years was 14138.25% (2025), contrasted with its biggest fall of 5721.84% (2025).
  • Microchip Technology's Cash & Equivalents (Quarter) stood at $313.5 million in 2021, then dropped by 7.85% to $288.9 million in 2022, then decreased by 2.73% to $281.0 million in 2023, then skyrocketed by 108.54% to $586.0 million in 2024, then tumbled by 57.22% to $250.7 million in 2025.
  • Its Cash & Equivalents stands at $250.7 million for Q4 2025, versus $236.8 million for Q3 2025 and $566.5 million for Q2 2025.